Cerevel (CERE) - Kapitalisasi marang bathi
Cerevel Therapeutics (CERE) development in neuromedicine is complicated by global conflicts affecting patent law and reagent supplies. This price chart on GURU.Markets confirms this, recording the indicator at -17.80. Cerevel Therapeutics (CERE) relies on external contractors for drug synthesis to minimize costs. Meanwhile, support from a powerful medical behemoth has ensured financial stability and the uninterrupted development of scientific research.
Rincian metrik komprehensif lan analitis Cerevel Therapeutics Inc (CERE)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Cerevel Therapeutics|CERE - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal cerevel.com|CERE - Utang perusahaan|Rasio utang marang kapitalisasi buku Cerevel Corp|CERE - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Cerevel Therapeutics|Rasio likuiditas perantara cerevel.com
- indikator bathi lan kelipatan valuasi:
CERE - Bathi resik|Penghasilan resik sing dikarepake Cerevel Therapeutics|CERE - Pangali P/E|Rasio prakiraan rega marang bathi Cerevel Corp|CERE - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cerevel Therapeutics Inc|CERE - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Cerevel Therapeutics|CERE - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan cerevel.com|CERE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Cerevel Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:Cerevel
Cerevel Therapeutics specializes in developing innovative therapies for severe central nervous system disorders. Analyzing the company's price-to-earnings ratio, an investor sees the current value of -17.80. This coefficient determines the payback period of the capitalization based on the generated net income. The metric's dynamics allow for an assessment of the market revaluation of biotech assets during periods of volatility. This helps determine the issuer's margin of safety relative to the industry benchmark.
Perusahaan pesaing
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Regencell (RGC) - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi axsome.com AXSM|Pangali P/E ACADIA Pharmaceuticals ACAD|XENE - Rasio rega marang bathi|Periode bali modal bisnis Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Rasio rega marang bathi|CPRX (Catalyst Pharmaceuticals) - Rasio rega marang bathi|DNLI (denalitherapeutics.com) - Pangali P/E|Pangali rega marang bathi HRMY (Harmony Biosciences Holdings, Inc.)|Pangali P/E BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Nilai perusahaan marang bathi resik|Pangali P/E TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalisasi marang bathi resik|anavex.com - Pangali P/E|Nilai perusahaan marang bathi resik CBLL (CeriBell, Inc.)|PRTA: Pangali P/E|Pangali rega marang bathi ALEC|ANNX (Annexon Biosciences Inc.) - Pangali P/E|omeros.com - Kapitalisasi marang bathi resik|Rasio rega marang bathi Neurogene (NGNE)|Periode bali modal bisnis AC Immune SA|Pangali P/E VYGR (voyagertherapeutics.com)|Pangali P/E Neumora NMRA|Scilex Holding - Pangali P/E|Kapitalisasi marang bathi Tevogen Bio Inc.|Alpha Cognition (ACOG) - Rasio rega marang bathi|cogrx.com (CGTX) - Pangali P/E|Rasio rega marang bathi Inhibikase Therapeutics|Cassava (SAVA) - Periode bali modal bisnis|Rasio rega marang bathi Assertio Therapeutics (ASRT)|Periode bali modal bisnis Coya|Vistagen - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OVID|Acumen Pharmaceuticals Inc. - Pangali P/E|Kapitalisasi marang bathi CervoMed Inc|ATHE: Pangali P/E|Koefisien rega marang bathi Clene Nanomedicine|Rasio rega marang bathi PepGen Corp|Jupiter Neurosciences (JUNS) - Periode bali modal bisnis|Rasio rega marang bathi Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalisasi marang bathi|gracetx.com - Koefisien rega marang bathi|AIFF: Pangali rega marang bathi|Klotho Neurosciences - Pangali P/E|NRSN (NeuroSense Therapeutics Ltd.) - Pangali rega marang bathi|Reviva Pharmaceuticals (RVPH) - Rasio rega marang bathi|MTVA (MetaVia Inc.) - Rasio rega marang bathi|Rasio rega marang bathi NeurAxis, Inc|Rasio rega marang bathi HSDT|Pangali P/E PASG|Periode bali modal bisnis Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Koefisien rega marang bathi|Pangali P/E Athira ATHA|Addex Therapeutics - Pangali P/E|ALZN - Pangali P/E|Cyclerion (CYCN) - Rasio rega marang bathi|Protagenic (PTIX) - Pangali P/E|Rasio rega marang bathi Pasithea|Pangali rega marang bathi CRGT (Cortigent)|Rasio rega marang bathi Avenue Therapeutics (ATXI)|BCLI - Kapitalisasi marang bathi|Pangali P/E CARA (Cara Therapeutics Inc)|CHRO - Koefisien rega marang bathi|ELYM: Koefisien rega marang bathi|Periode bali modal bisnis Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Rasio rega marang bathi|Marinus - Nilai perusahaan marang bathi resik|Rasio rega marang bathi NKGen Biotech Inc|NRBO: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SAGE (Sage Therapeutics, Inc.)|Periode bali modal bisnis Neurotrope|Rasio rega marang bathi Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Kapitalisasi marang bathi|WENA: Koefisien rega marang bathi
